Pres, Innovation, Tech Aubrey Rankin sold $1.6M of Revance Therapeutics, Inc.

Sold$1,632,960

$30.06Price

54,332Shares

−9%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Wed, Jul 28. Filed Fri, Jul 30, 4:57 PM ET, after the close. Not investment advice.